Sorin Group
Sorin Group was a Milan-headquartered global medical device company specializing in cardiovascular products, including tissue heart valves and heart-lung bypass machines, serving cardiac surgery hospitals and surgeons worldwide until its 2015 merger with Cyberonics to form LivaNova PLC.
- Company typePrivate
- Founded2004
- HeadquartersMilan, Italy
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sorin Group does
Sorin Group was a Milan-headquartered global medical device company specializing in the treatment of cardiovascular diseases. Its core product portfolio included tissue heart valves and heart-lung bypass (perfusion) machines, devices used by cardiac surgeons, perfusionists, and hospitals performing open-heart surgery and valve replacement procedures. With a workforce of 5,001-10,000 employees, the company operated at the scale required for global manufacturing, regulatory compliance across the U.S. and EU, and clinical evidence generation typical of Class III implantable and capital cardiovascular equipment. The company is identified as a key industry participant alongside Medtronic, Edwards Lifesciences, Abbott, Terumo, Maquet, Getinge, and LivaNova.
The company's business model was that of a traditional medical device manufacturer: it developed, manufactured, and sold regulated cardiac surgery products to hospitals and healthcare systems globally, monetizing through capital equipment sales (heart-lung bypass machines) and recurring implantable revenue (tissue heart valves). Go-to-market relied on direct sales relationships with cardiac surgery centers and surgeon training programs. Strategic activity over its independent life included the 2010 acquisition of Gish Biomedical and the 2014 acquisition of Oscor, both aimed at broadening the cardiac surgery product portfolio.
In 2015, Sorin Group ceased to exist as an independent entity through an all-stock merger with Cyberonics valued at approximately $2.7 billion, combining to form LivaNova PLC. Successor products associated with Sorin's heritage — such as the Essenz Perfusion System — continue to appear on the LivaNova product portfolio, indicating that the cardiac surgery franchise was retained within the combined company rather than divested.
Sorin Group firmographics
Firmographics- Name
- Sorin Group
- Website
- https://sorin.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Acquired
- Headcount range
- 5,001–10,000 employees
- Short description
- Sorin Group was a Milan-headquartered global medical device company specializing in cardiovascular products, including tissue heart valves and heart-lung bypass machines, serving cardiac surgery hospitals and surgeons worldwide until its 2015 merger with Cyberonics to form LivaNova PLC.
- Ownership category
- akta.pro rank
Sorin Group industry classification
Industry- Product category
- Cardiovascular Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)
Keywords
Where Sorin Group is headquartered
LocationHeadquarters
- HQ city
- Milan
- HQ country
- Italy
- HQ region
- Europe
Markets served
Sorin Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Sorin Group product offering
Product offeringCore offering
Sorin Group is a global medical device company that designs, manufactures, and sells cardiovascular products, with a core focus on tissue heart valves and heart-lung bypass machines used in cardiac surgery. The company served hospitals and cardiac surgery centers worldwide as a key participant in the cardiovascular medical devices market alongside major players such as Medtronic, Edwards Lifesciences, Boston Scientific, and Abbott. Sorin Group operated as an independent entity until its 2015 merger with Cyberonics to form LivaNova PLC.
Product overview
Sorin Group operates in the cardiac medical devices sector, specifically in the tissue heart valves and heart-lung bypass machine markets. The company is identified as a market participant in cardiovascular surgery devices and equipment, competing alongside major industry players such as Medtronic, Boston Scientific, Edwards Lifesciences, and Abbott. Specific product names, models, and technical specifications are not detailed in the available source materials.
Differentiator
Problem solved
Functional benefit
Products and services
- Tissue Heart Valves
Companies that use Sorin Group
Customer profileIdeal customer profiles1 record
Sorin Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sorin Group partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights3 records
Sorin Group competitors and assessment
Company assessmentDirect peers
- Edwards Lifesciences: Edwards Lifesciences is a direct peer in tissue and transcatheter heart valves; the company data explicitly lists Edwards as a competitor to Sorin Group in the tissue heart valves market alongside Medtronic, Boston Scientific, and Abbott.
- Medtronic: Medtronic is named in both the heart-lung bypass and tissue heart valves scale_commentary entries as a direct competitor to Sorin Group; the two companies overlap in cardiac surgery devices, heart valves, and cardiopulmonary equipment.
- LivaNova: LivaNova is the direct successor entity formed by the 2015 merger of Sorin Group and Cyberonics; it now owns and operates Sorin's former cardiac surgery, heart valve, and cardiopulmonary businesses, including the Essenz Perfusion System highlighted on its website.
- Terumo Corporation: Terumo is listed in source as a key competitor to Sorin Group in the heart-lung bypass machine market and is a direct competitor in cardiopulmonary perfusion equipment and oxygenators.
- Getinge Group (Maquet Cardiopulmonary): Maquet Cardiopulmonary (now part of Getinge) is listed alongside Sorin Group as a key player in the heart-lung bypass machine market; the two compete directly in cardiopulmonary bypass and perfusion systems.
Broad incumbents
- Abbott Laboratories: Abbott is named in source as a competitor to Sorin Group in the tissue heart valves market; it is a broader incumbent across cardiovascular devices, structural heart, and hospital products.
- Boston Scientific: Boston Scientific is cited in source as a competitor to Sorin Group in the tissue heart valves market; it is a broad incumbent in interventional cardiology and structural heart devices.
Emerging players
- CryoLife: CryoLife is listed in source as a peer in the tissue heart valves market; it is a smaller, focused competitor in cardiac and vascular preserved tissue and valves.
- JenaValve Technology: JenaValve Technology is referenced in source as a peer in the tissue heart valves market; it is an emerging, niche player focused on transcatheter aortic valve repair for aortic regurgitation.
Regional players
- MicroPort Scientific: MicroPort is a cardiovascular device competitor through its cardiac surgery and structural heart businesses and is comparable in scope to Sorin's cardiac surgery portfolio, primarily serving Asia-Pacific rather than overlapping directly with Sorin's European base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Sorin Group social profiles
Digital presenceSorin Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sorin Group leadership team
Management profileNumber of profiles
Sorin Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sorin Group M&A and investment
M&A and investmentM&A2 records
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sorin Group
What does Sorin Group do?
Sorin Group is a global medical device company that designs, manufactures, and sells cardiovascular products, with a core focus on tissue heart valves and heart-lung bypass machines used in cardiac surgery. The company served hospitals and cardiac surgery centers worldwide as a key participant in the cardiovascular medical devices market alongside major players such as Medtronic, Edwards Lifesciences, Boston Scientific, and Abbott. Sorin Group operated as an independent entity until its 2015 merger with Cyberonics to form LivaNova PLC.
Is Sorin Group a public or private company?
Sorin Group is a private company. It is classified as unknown and is currently acquired.
When was Sorin Group founded?
Sorin Group was founded in 2004. It employs 5,001 to 10,000 people.
Where is Sorin Group based?
Sorin Group is headquartered in Milan, Italy, in the Europe region.
Who are Sorin Group's main competitors?
Direct peers on record are Edwards Lifesciences, Medtronic, LivaNova, Terumo Corporation and Getinge Group (Maquet Cardiopulmonary). Broad incumbents are Abbott Laboratories and Boston Scientific. Emerging players are CryoLife and JenaValve Technology. MicroPort Scientific is listed as a regional player.
Does Sorin Group have an API?
No public API is recorded for Sorin Group.
What industry is Sorin Group in?
Sorin Group's product category is Cardiovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAB, Structural Heart Valves (TAVR/SAVR) & Valve Repair. Its NAICS code is 334510 and its SIC code is 3842.